Rate My Professor Cath Drummond

Drummond contributes to education through supervision of PGDip MLSc and PhD candidates, tutoring in ELM2 (clinical pathology) and PSCI 202 (Medicines and Disease), and guest lecturing in PATH 302. Her scholarly output includes recent publications such as 'MicroRNA mimics based on the miR-15/107 consensus sequence sensitise NSCLC cells to targeted therapy' (2026, International Journal of Molecular Sciences, with C. Carpenter et al.); 'Δ133p53 isoform enhances TLR4 function to promote tumour growth' (2025, Carcinogenesis, with S. Polwatta Lekamlage et al.); and earlier works like 'A DHODH inhibitor increases p53 synthesis and enhances tumor cell death' (2018). She has presented at conferences, including Queenstown Research Week meetings in 2024 on topics such as drug repurposing for drug tolerant persisters and the role of lncRNA MALAT1 in lung adenocarcinoma drug resistance. Her work advances knowledge in cancer therapy resistance mechanisms and p53-related pathways.